Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | EXICURE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
Fr | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
10.06. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
EXICURE Aktie jetzt für 0€ handeln | |||||
28.05. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | Exicure receives Nasdaq non-compliance notice for late quarterly filing | 1 | Seeking Alpha | ||
28.05. | Exicure faces Nasdaq non-compliance notice | 1 | Investing.com | ||
06.05. | EXICURE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
14.04. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.03. | Pre-market Movers: Y-mAbs Therapeutics, Aveanna Healthcare, UiPath, Exicure, CareCloud | 624 | AFX News | SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Aveanna Healthcare Holdings Inc. (AVAH) is up... ► Artikel lesen | |
05.03. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
21.02. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
23.01. | Exicure, back from brink and under new management, buys GPCR's US unit and clinical-stage drug | 2 | FierceBiotech | ||
23.01. | Exicure Buys GPCR USA From GPCR Therapeutics, Signs L&C Deal; Stock Climbs | 1 | RTTNews | ||
22.01. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
06.01. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
27.12.24 | Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech | 206 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "Exicure", "the Company"), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics")... ► Artikel lesen | |
20.12.24 | Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes | 295 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "the Company", "Exicure"), today announced that in connection with the change of control transaction approved by the stockholders at the Special... ► Artikel lesen | |
04.12.24 | Pre-market Movers: Heron Therapeutics, Oriental Rise Holdings, Exicure, Pure Storage, Cheetah Net Supply Chain Service | 1.140 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.10 A.M. ET).In the Green Heron Therapeutics, Inc. (HRTX) is up over 66%... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVARTIS | 102,84 | +0,21 % | Novartis Pharma AG: Novartis completes acquisition of Regulus Therapeutics | Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of common... ► Artikel lesen | |
GILEAD SCIENCES | 94,33 | -0,18 % | Assembly Biosciences: ABI-4334 erreicht Studienziel - Gilead-Entscheidung steht bevor | Assembly Biosciences (WKN: A402CB) liefert weiter ab: Mit ABI-4334 fällt der erste wichtige Readout dieses Jahres positiv aus. Das HBV-Asset galt als das unsicherste im Portfolio. Die Aktie liebäugelt... ► Artikel lesen | |
AURORA CANNABIS | 3,540 | +0,28 % | Aurora Cannabis Inc (3): Aurora Cannabis expands compassionate pricing program | ||
CANOPY GROWTH | 1,036 | -0,19 % | Canopy Growth Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
ELI LILLY | 670,70 | -1,27 % | Eli Lilly and Company: Lilly declares third-quarter 2025 dividend | INDIANAPOLIS, June 23, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2025... ► Artikel lesen | |
MERCK & CO | 67,40 | -0,15 % | Merck & Co.: Patente, Prognosen und eine fatale Fehleinschätzung | Auslaufende Patente, geopolitische Risiken, Abschreibungen. Merck steht unter Druck, doch abseits der Schlagzeilen läuft das Geschäft erstaunlich gut Den vollständigen Artikel lesen ... ► Artikel lesen | |
ASTRAZENECA | 120,05 | +0,42 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Die beschleunigte US-Zulassung von Datroway gegen... ► Artikel lesen | |
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,344 | +0,09 % | Tilray Brands, Inc.: Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke | SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem... ► Artikel lesen | |
INNOCAN PHARMA | 0,145 | +2,11 % | Breaking News: Innocan Pharma - der Superstar auf der "PAINWEEK"? | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
ARZNEIWERK AG VIDA | 0,575 | -5,74 % | PTA-News: Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien | DJ PTA-News: Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien
Unternehmensmitteilung für den Kapitalmarkt
Arzneiwerk AG VIDA: Börsenzulassung von 226.155 Aktien
Berlin (pta000/16.06.2025/12:00... ► Artikel lesen | |
CRONOS GROUP | 1,614 | -0,31 % | Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders | TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 8,400 | +1,89 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 34,010 | +0,06 % | H.C. Wainwright bestätigt Kaufempfehlung für Ionis Pharmaceuticals-Aktie bei 50 US-Dollar |